General Catalyst Group Management, LLC
- SEC CIK
- 0001637946
- Latest filing
- Aug 14, 2026
MAZE holding history
Maze Therapeutics, Inc. in every 13F filed by General Catalyst Group Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MAZE overviewAll 13F holders of MAZEFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,035,910
- Value
- $30.9M
- % of portfolio
- 16.4%
- Quarters held
- 6
- Since Q1 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,035,910 | $30.9M | 16.4% | 00.0% | Unchanged | Holders |
| Q1 2026 | 1,035,910 | $30.9M | 16.8% | 00.0% | Unchanged | Holders |
| Q4 2025 | 1,035,910 | $42.9M | 19.4% | 00.0% | Unchanged | Holders |
| Q3 2025 | 1,035,910 | $26.9M | 0.9% | 00.0% | Unchanged | Holders |
| Q2 2025 | 1,035,910 | $12.7M | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2025 | 1,035,910 | $11.4M | 1.3% | +1,035,910 | New | Holders |